Raphael is a training psychiatrist now working as a clinical research fellow at SLAM. He has an interest in medical education having completed a PGCert in Education and a year as a clinical teaching fellow in Bristol. In terms of research, Raphael is interested in psychopharmacology and especially novel psychotherapeutics. He is trained at the University of Oxford, where he also completed a BA in Cellular physiology and pharmacology.
Raphael Rifkin-Zybutz and Sameer Jauhar summarise the recently published ANTLER trial, which explores whether antidepressant maintenance can reduce the risk of relapse in depression.
